159 results on '"Davidge-Pitts, Caroline J"'
Search Results
2. Clinical features and outcomes in primary nervous system histiocytic neoplasms
3. Transgender Women Exhibit a Distinct Stress Echocardiography Profile Compared With Age-Matched Cisgender Counterparts: The Mayo Clinic Women’s Heart Clinic Experience
4. Neurological Manifestations of Histiocytic Disorders
5. Long-term outcomes among adults with Langerhans cell histiocytosis
6. Comparison of the Subcutaneous and Intramuscular Estradiol Regimens as Part of Gender-Affirming Hormone Therapy
7. Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes
8. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
9. SLC29A3 Pathogenic Variants Resulting in Dural Based Fibroinflammatory Mass Lesions and H Syndrome Treated With Cobimetinib: A Case Report.
10. Characteristics of Transgender Women Referred to Women's Heart Clinic
11. Pituitary Tumor Surgery: Comparison of Endoscopic and Microscopic Techniques at a Single Center
12. A Comprehensive Study of Spindle Cell Oncocytoma of the Pituitary Gland: Series of 6 Cases and Meta-Analysis of 85 Cases
13. Correlation of older age with better progression-free survival despite less aggressive resection in nonfunctioning pituitary adenomas.
14. Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis
15. Transgender Women Exhibit a Distinct Stress Echocardiography Profile Compared to Age-Matched Cisgender Counterparts: The Mayo Clinic Women’s Heart Clinic Experience
16. Correlation of older age with better progression-free survival despite less aggressive resection in nonfunctioning pituitary adenomas
17. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease
18. Transfeminine Hormone Therapy
19. Cardiopulmonary Exercise Testing in Transgender and Gender-Diverse Patients
20. Hidradenitis suppurativa in transgender and gender diverse patients: a retrospective review with examination of the role of hormone therapy
21. Endocrinology Fellows' Perception of Their Confidence and Skill Level in Providing Transgender Healthcare
22. Reply
23. A community-based study of demographics, medical and psychiatric conditions, and gender dysphoria/incongruence treatment in transgender/gender diverse individuals
24. Hidradenitis suppurativa in transgender and gender diverse patients: A retrospective review with examination of the role of hormone therapy
25. Primary adrenal insufficiency due to bilateral infiltrative disease
26. Machine Learning-Based Model to Predict Long-Term Tumor Control and Additional Interventions following Pituitary Surgery for Cushing's Disease.
27. A 64-year-Old patient assigned male at birth with COPD and worsening dyspnea while on estrogen and antiandrogen agents
28. Hypoglycemia in the Nondiabetic Patient
29. High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group
30. Efficacy of MEK Inhibitors in Erdheim Chester Disease
31. Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis
32. Breaking Down Barriers to Reproductive Care for Transgender People
33. Letter to the Editor. The value of an engaged endocrine practice may outweigh patient factors
34. 133 Investigating the Utilization Rate of Fertility Preservation Services Amongst Transgender and Gender Diverse Patients
35. Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience
36. Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.
37. Efficacy of Cobimetinib in Rosai-Dorfman Disease
38. 機能性FSH産生性下垂体腺腫の特徴と治療成績
39. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
40. Dermatologic disorders in transgender patients: A retrospective cohort of 442 patients
41. Hypoglycemia in the Nondiabetic Patient
42. Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms
43. Transgender Health Care Curriculum Development: A Dual-Site Medical School Campus Pilot
44. Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease.
45. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study:a prospective test validation study
46. Mimics of Erdheim–Chester disease.
47. Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”
48. Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis.
49. Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing
50. Effect of Sex Steroids on the Bone Health of Transgender Individuals: A Systematic Review and Meta-Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.